Company / Return on Equity (ROE)
ANI Pharmaceuticals, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
14.5%
FY2025
5-year range
-15.3% / 14.5%
FY2021-FY2025
Trend
+415.7%
vs FY2024
Sector context
#30 of 190
Health Care
What the data says
Return on Equity (ROE) changed +416% YoY in FY2025, a notable deviation from the 9-year average annual change of +109%.
Based on SEC 10-K filings.
14.5% in FY2025 with a 5-year CAGR of +26.0%. Top quartile in the Health Care sector.
Improved from 4.3% to 14.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +29.8pp
- 5-Year Change
- +26.0pp
- 10-Year Change
- -
Sector benchmark
Top 16% in Health CareTop 16% of 190This company 14.5% Sector average -50.3%
▼
+128.8% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 415.7% year-over-year.
- Currently 64.8pp above the Health Care sector average.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.5% | +415.7% |
| FY2024 | -4.6% | -205.8% |
| FY2023 | 4.3% | +128.4% |
| FY2022 | -15.3% | -19.7% |
| FY2021 | -12.8% | -10.8% |
| FY2020 | -11.5% | -502.8% |
| FY2019 | 2.9% | -63.6% |
| FY2018 | 7.8% | +1366.1% |
| FY2017 | -0.6% | -126.7% |
| FY2016 | 2.3% | +217.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026